Sun Pharma Acquires Organon in $11.75 Billion Deal
Sun Pharmaceutical Industries has agreed to acquire Organon & Co. for $11.75 billion in an all-cash transaction. The deal, which requires regulatory and shareholder approvals, is expected to close in early 2027. The acquisition is expected to position the combined entity as one of the top 25 global drugmakers and a leading biosimilar and women's health player.
Topics: acquisition global expansion Organon pharmaceutical industry Sun Pharma